Dermal Fillers Market Scope And Analysis

Report Code : TIPRE00002992
Category : Pharmaceuticals

Status : Published
No. of Pages : 195

Buy Now

Dermal Fillers Market Analysis Report 2024 to 2031

Buy Now

Dermal Fillers Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 4.00 Billion
Market Size by 2031	US$ 7.58 Billion
Global CAGR (2023 - 2031)	8.3%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Biodegradable and Nonbiodegradable By Material Calcium Hydroxylapatite Hyaluronic Acid Collagen Poly-L-Lactic Acid Polmethylmethacrylate Fat Fillers By Application Facial Line Correction Treatment Lip Enhancement Face Lift Scar Treatment By End User Multispecialty Hospitals Dermatology Clinics Ambulatory Surgical Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	AbbVie Inc Galderma SA Merz Pharma GmbH Co KGaA Suneva Medical Bioxis Pharmaceuticals Bioplus Co Ltd Teoxane Laboratories Bioha Laboratories Prollenium Medical Technologies Sinclair Pharma Ltd

Industry Developments and Future Opportunities:

The dermal fillers market report includes company positioning and concentration to evaluate the performance of competitors in the market. As per company press releases, below are a few initiatives taken by key players operating in the market:

In September 2023, Merz Aesthetics received the US Food and Drug Administration (FDA) approval for Belotero Balance (+) for volume augmentation for the improvement of the infraorbital hollow in adults above the age of 21, further increasing the usage and capability of Belotero Balance (+), and addressing consumer under-eye concerns.
In June 2023, Galderma received the US FDA approval for its Restylane Eyelight. Restylane Eyelight can be used to treat undereye hollows in adults aged 21 and above. Restylane Eyelight, an undereye hyaluronic acid dermal filler, is the first and only product in the US formulated with NASHA technology for volume loss under the eyes, giving patients natural-looking results.

Competitive Landscape and Key Companies:

The dermal fillers market forecast can help stakeholders plan their growth strategies. AbbVie Inc, Galderma SA, Merz Pharma GmbH & Co KGaA, Suneva Medical, Bioxis Pharmaceuticals, Bioplus Co. Ltd., Teoxane Laboratories, Bioha Laboratories, Prollenium Medical Technologies, and Sinclair Pharma Ltd are among the prominent players in the market. The market players focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.